Marco Vaccines — No doubt should cost a vaccination

Marco Vaccines · Immunization

No doubt should cost a vaccination.

Technical answers about vaccines in seconds, cross-checking the national schedule against international recommendations. For whoever vaccinates, wherever they vaccinate.

In collaboration with the Pan American Health Organization, national governments and local organizations.

The problem

The barrier isn't demand. It's the doubt of whoever vaccinates.

Eligible person

no contraindications

Reaches the service

contact happens

Leaves unvaccinated

missed opportunity

Main cause identified in assessments using WHO methodology: false contraindications applied by health workers.

83%

did not correctly identify valid contraindications

Burkina Faso · 248 vaccinators

46%

report concern about adverse events

Jordan · 432 providers

41%

of eligible children experienced a missed opportunity for vaccination

Timor-Leste · national assessment

Published national assessments, carried out using the WHO missed opportunities for vaccination methodology. They do not correspond to Marco deployments.

What it answers

The questions that come up with the person standing there.

Contraindications

Which ones are real and which aren't.

Interrupted schedules

How to continue without restarting the schedule.

Intervals and co-administration

What can be given in the same visit.

Special populations

Pregnancy, immunocompromise, preterm infants, older adults.

Adverse events

AEFI: what to expect, what to report and what to do.

Storage and cold chain

Shelf life and temperature excursions.

Every answer shows its source: the country's current schedule, a WHO position paper or primary literature.

How it reaches them

Where the vaccinator already is, with no new equipment.

Phone

In the pocket of whoever vaccinates, with nothing to install.

Messaging

In the app they already use every day.

Chart or system

Integrated into the electronic immunization registry or the local system.

Without a stable connection

Short answers, low data consumption.

What no global tool solves

The recommendation is international. The decision is national.

International layer

WHO position papers, evidence and recommendations from reference bodies.

National layer

The country's current schedule, available presentations, campaigns and programme policy.

An answer that can be acted on at that vaccination post.

A general-purpose assistant cites the international recommendation, but doesn't know which vaccines are available in that country today, what its schedule says, or which campaign is under way. Without that, the answer can't be acted on.

The asset nobody else produces

What the field asks is public health information.

Questions from the field

anonymous and aggregated

Where the doubt concentrates

by region, vaccine and topic

Programme decision

targeted training and communication

The programme stops detecting knowledge gaps through an annual survey and starts seeing them within weeks, with the detail of what is being asked and where.

Value by stakeholder

Coverage for the country, backing for whoever vaccinates.

Governments

  • More coverage with no new infrastructure.
  • Schedule changes in days, not in training cycles.
  • Equity: the same answer in the capital and at the rural post.

International organizations

  • The recommendation reaches the last mile.
  • Measurement of real use of the guidance in the field.
  • One deployment replicable across countries.

Health workers

  • An answer in seconds, with the person standing there.
  • Backing to decide and to explain to the caregiver.
  • No prior training and no extra equipment.

Marco Vaccines informs. The health worker decides. It does not prescribe and does not replace programme policy: it delivers the answer with its source so it can be verified.

Security and compliance ISO 27001 SOC 2 GDPR EU AI Act alignment in progress

How it starts

From a programme to a deployment, in three steps.

Sources

Loading the national schedule and the programme's own policy.

Pilot

A defined territory, with agreed indicators.

Scale

The whole country, with no new build.

Who we work with

Sociedad Argentina de Vacunas Pan American Health Organization Pfizer

Get started

Every contact is an opportunity to vaccinate.

To discuss a pilot deployment in your country and the indicators it would be measured against.

Get in touch
Update cookies preferences